Cargando…
Polymer Microparticles Prolong Delivery of the 15-PGDH Inhibitor SW033291
As the prevalence of age-related fibrotic diseases continues to increase, novel antifibrotic therapies are emerging to address clinical needs. However, many novel therapeutics for managing chronic fibrosis are small-molecule drugs that require frequent dosing to attain effective concentrations. Alth...
Autores principales: | Dogan, Alan B., Rohner, Nathan A., Smith, Julianne N. P., Kilgore, Jessica A., Williams, Noelle S., Markowitz, Sanford D., von Recum, Horst A., Desai, Amar B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779392/ https://www.ncbi.nlm.nih.gov/pubmed/35056981 http://dx.doi.org/10.3390/pharmaceutics14010085 |
Ejemplares similares
-
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
por: Smith, Julianne N. P., et al.
Publicado: (2020) -
Effects of SW033291 on the myogenesis of muscle-derived stem cells and muscle regeneration
por: Dong, Yuanqiang, et al.
Publicado: (2020) -
15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration
por: Smith, Julianne N.P., et al.
Publicado: (2021) -
15-PGDH regulates hematopoietic and gastrointestinal fitness during aging
por: Ho, Won Jin, et al.
Publicado: (2022) -
3D GelMA ICC Scaffolds Combined with SW033291 for Bone Regeneration by Modulating Macrophage Polarization
por: Jiang, Qian, et al.
Publicado: (2021)